Future Prospects And Stock Pricing Of Elanco Animal Health Inc (NYSE: ELAN)

In the last trading session, 4.79 million shares of the Elanco Animal Health Inc (NYSE:ELAN) were traded, and its beta was 1.35. Most recently the company’s share price was $13.46, and it changed around $0.53 or 4.10% from the last close, which brings the market valuation of the company to $6.64B. ELAN currently trades at a discount to its 52-week high of $16.88, offering almost -25.41% off that amount. The share price’s 52-week low was $7.88, which indicates that the current value has risen by an impressive 41.46% since then. We note from Elanco Animal Health Inc’s average daily trading volume that its 3-month average coming to 4.15 million.

Elanco Animal Health Inc stock received a consensus recommendation rating of Hold, based on a mean score of 2.00. If we narrow it down even further, the data shows that 0 out of 11 analysts rate the stock as a Sell; another 1 rate it as Overweight. Among the rest, 6 recommended ELAN as a Hold, whereas 4 deemed it a Buy, and 0 rated it as Underweight. Elanco Animal Health Inc is expected to report earnings per share of $0.26 for the current quarter.

Elanco Animal Health Inc (NYSE:ELAN) trade information

Instantly ELAN has showed a green trend with a performance of 4.10% at the end of last trading. The performance over the last five days has remained in the red territory. The company’s shares are currently down -9.66% year-to-date, but still down -1.32% over the last five days. On the other hand, Elanco Animal Health Inc (NYSE:ELAN) is -14.92% down in the 30-day period.

The consensus price target as assigned by Wall Street analysts is $26.17, which translates to bulls needing to increase their stock price by 48.57% from its current value. Analyst projections state that ELAN is forecast to be at a low of $18 and a high of $37.

Elanco Animal Health Inc (ELAN) estimates and forecasts

Elanco Animal Health Inc share prices are performing particularly well not compared to other companies within the same industry. As is evident from the statistics, the company’s shares have risen 46.94 percent over the past six months and at a 2.25% annual growth rate that is well below the industry average of 11.50%. Moreover, analysts have decided to roll up on their fiscal year 2024 revenue estimates. The rating firms predict that it will loss -42.20% in revenue this quarter, and will report an increase of 33.30% in the next quarter. The year-over-year growth rate is expected to be 1.80%, up from the previous year.

Consensus estimates provided by 9 financial analysts predict the company will bring in an average of $1.17 billion in revenue for the current quarter. 9 analysts expect Elanco Animal Health Inc to make $1.15 billion in revenue for the quarter ending Jun 2024. The company’s sales for the same quarters a year ago were $1.26 billion and $1.06 billion respectively. Analysts predict that the company’s current quarter sales will drop, forecast at -6.50%. Forecasts for the next quarter put sales growth at 9.10%.

Elanco Animal Health Inc earnings are expected to increase by 3.44% in 2024, but the outlook is positive 8.87% per year for the next five years.